Cargando…

Assessment of the physical dependence potential of difelikefalin: Randomized placebo‐controlled study in patients receiving hemodialysis

Difelikefalin is a selective kappa opioid receptor agonist approved for treating moderate‐to‐severe pruritus in adults undergoing hemodialysis (HD). Difelikefalin is not a controlled substance under the Controlled Substances Act. This study assessed the potential for developing physical dependence o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spencer, Robert H., Munera, Catherine, Shram, Megan J., Menzaghi, Frédérique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499405/ https://www.ncbi.nlm.nih.gov/pubmed/37128642 http://dx.doi.org/10.1111/cts.13538

Ejemplares similares

Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients
por: Fishbane, Steven, et al.
Publicado: (2020)

Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users
por: Shram, Megan J., et al.
Publicado: (2021)

Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study
por: Weiner, Daniel E., et al.
Publicado: (2022)

Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis
por: Stark, Jeffrey G., et al.
Publicado: (2023)

Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program
por: Fishbane, Steven, et al.
Publicado: (2022)

Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies
por: Topf, Joel, et al.
Publicado: (2022)

Efficacy and Safety of Difelikefalin in Japanese Patients With Moderate to Severe Pruritus Receiving Hemodialysis: A Randomized Clinical Trial
por: Narita, Ichiei, et al.
Publicado: (2022)

Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double‐blind, placebo‐controlled trial
por: Viscusi, Eugene R., et al.
Publicado: (2021)

Difelikefalin: A Novel Therapy for Dialysis Patient Care
por: Watnick, Suzanne, et al.
Publicado: (2022)

Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus
por: Vernon, Margaret K., et al.
Publicado: (2021)

Difelikefalin in the Treatment of Chronic Kidney Disease-Associated Pruritus: A Systematic Review
por: Wala, Kamila, et al.
Publicado: (2022)

The Burden of Pruritus Associated With CKD: A Mixed Methods Analysis Among Patients Undergoing Dialysis
por: Menzaghi, Frédérique, et al.
Publicado: (2023)

Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis
por: Thokala, Praveen, et al.
Publicado: (2023)

Utility of a Single Itch-Related Question and the Skindex-10 Questionnaire for Assessing Pruritus and Predicting Health-Related Quality of Life in Patients Receiving Hemodialysis
por: Lopes, Marcelo Barreto, et al.
Publicado: (2022)

Physical activity is a potential measure of physical resilience in older adults receiving hemodialysis
por: Lucas, Anika, et al.
Publicado: (2023)

“Machine-Dependent”: The Lived Experiences of Patients Receiving Hemodialysis in Pakistan
por: Shouket, Haseeba, et al.
Publicado: (2022)

Self-reported Physical Function Decline and Mortality in Older Adults Receiving Hemodialysis
por: Hall, Rasheeda K., et al.
Publicado: (2019)

Torus Mandibularis in Patients Receiving Hemodialysis
por: Chang, Pei-Ching, et al.
Publicado: (2021)

Performance of a brief survey to assess health literacy in patients receiving hemodialysis
por: Cavanaugh, Kerri L., et al.
Publicado: (2015)

The impact of muscle mass loss and deteriorating physical function on prognosis in patients receiving hemodialysis
por: Kitamura, Mineaki, et al.
Publicado: (2021)

Physical Function Assessment in Older Hemodialysis Patients
por: Hall, Rasheeda K., et al.
Publicado: (2020)

Abuse Potential of Intravenous Oxycodone/Naloxone Solution in Nondependent Recreational Drug Users
por: Colucci, Salvatore V., et al.
Publicado: (2014)

Intractable ascites in a female receiving hemodialysis
por: Tungsanga, Somkanya, et al.
Publicado: (2023)

Risks associated with continuation of potentially inappropriate antihypertensive medications in older adults receiving hemodialysis
por: Hall, Rasheeda K., et al.
Publicado: (2021)

REL-1017 (esmethadone; d-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley rats
por: Henningfield, Jack, et al.
Publicado: (2022)

Unmet Needs of Older Adults Receiving In-Center Hemodialysis: A Qualitative Needs Assessment
por: Hall, Rasheeda, et al.
Publicado: (2020)

Serum Prealbumin: a potential predictor of Right Ventricular Dysfunction in patients receiving programmed hemodialysis
por: Gok, Murat, et al.
Publicado: (2022)

Systemic Treatments for Lung Cancer Patients Receiving Hemodialysis
por: Leung, Tzewah V., et al.
Publicado: (2018)

Sarcopenia among patients receiving hemodialysis: weighing the evidence
por: Kittiskulnam, Piyawan, et al.
Publicado: (2016)

Rectal ulcer in a hemodialysis patient receiving Kayexalate(®)
por: Collot, Julia, et al.
Publicado: (2021)

Factors Affecting Quality of Life in Patients Receiving Hemodialysis
por: A Lim, Kyung, et al.
Publicado: (2022)

Self-reported Pruritus and Clinical, Dialysis-Related, and Patient-Reported Outcomes in Hemodialysis Patients
por: Sukul, Nidhi, et al.
Publicado: (2020)

Physical Activity versus Sclerostin and Interleukin 6 Concentration in Patients Receiving Renal Replacement Therapy by Hemodialysis
por: Turoń-Skrzypińska, Agnieszka, et al.
Publicado: (2020)

Hypokalemia Events With Sodium Zirconium Cyclosilicate and Placebo in Hemodialysis Patients
por: Fishbane, Steven, et al.
Publicado: (2022)

Challenging Received Wisdom: Antidepressants and the Placebo Effect
por: Kirsch, Irving
Publicado: (2008)

Effect of Auricular Acupressure on Uremic Pruritus in Patients Receiving Hemodialysis Treatment: A Randomized Controlled Trial
por: Yan, Cui-na, et al.
Publicado: (2015)

A Prospective, Randomized Clinical Trial of Etelcalcetide in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism (the DUET Trial)
por: Itano, Yuya, et al.
Publicado: (2020)

Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study
por: Aramwit, Pornanong, et al.
Publicado: (2012)

Comment on “Serum prealbumin: a potential predictor of right ventricular dysfunction in patients receiving programmed hemodialysis”
por: Fang, Longcai, et al.
Publicado: (2023)

Correlation between Physical Activity and Psychological Distress in Patients Receiving Hemodialysis with Comorbidities: A Cross-Sectional Study
por: Wu, Yu-Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_486hfjafklnihpk68ttcna7i7a